Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01950533 · ClinicalTrials.gov registry record
The Utility of Food-Specific IgE Measured With the IMMULITE 2000 Assay to Predict Symptomatic Food Allergy
A clinical trial, sponsored by National Jewish Health.
- Completed
- Registry status
- 102
- Enrollment target
NCT01950533 is a clinical trial that has completed, run by National Jewish Health. The registered enrollment target is 102 participants.
The verdict
NCT01950533 has completed, sponsored by National Jewish Health.
- COMPLETED
- Registry status
- 102 participants
- Enrollment target
Study Summary
Food allergy is on the rise within the pediatric population. Having food allergy can cause medical, nutritional and psychological issues in those who suffer with it. Although making the appropriate diagnosis of food allergy is very important, properly diagnosing food allergy has been a challenge. Skin prick testing and food-specific IgE testing of the blood can give positive results that are false. Currently, Oral Food Challenges are the best way to diagnose a food allergy. Unfortunately, Oral Food Challenges are time consuming and may not be readily available to suspected food allergy sufferers. This study is designed to examine the effectiveness of an allergy-detecting blood test called IMMULITE 2000 manufactured by the study sponsor, Siemens.
Interventions
- PROCEDURE Oral food challenge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2013-09 |
| Est. Completion | 2017-03-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01950533
The ClinicalTrials.gov registry entry for NCT01950533 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Jewish Health, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oral food challenge is the first listed.
NCT01950533 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01950533 about?
NCT01950533 is a clinical study titled "The Utility of Food-Specific IgE Measured With the IMMULITE 2000 Assay to Predict Symptomatic Food Allergy". Food allergy is on the rise within the pediatric population. Having food allergy can cause medical, nutritional and psychological issues in those who suffer with it. Although making the appropriate diagnosis of food allergy is very important, properly diagnosing food allergy has been a challenge. Sk...
What is the current status of trial NCT01950533?
This trial is currently completed. The enrollment target is 102 participants. The study started on 2013-09. Estimated completion is 2017-03-29.
What interventions are being tested in trial NCT01950533?
The interventions under investigation include: Oral food challenge (PROCEDURE).
Who is sponsoring clinical trial NCT01950533?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.